SCHEMBL31350596

SCHEMBL31350596

Cc1cnc(NC#N)c(C#N)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRK1 P41145 1/20 0.36
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
GLA P06280 2/20 0.34
KDM4E B2RXH2 4/20 0.33
NPSR1 Q6W5P4 3/20 0.33
RXFP1 Q9HBX9 3/20 0.33
GAA P10253 3/20 0.33
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
CCR1 P32246 1/20 0.31
CCR5 P51681 1/20 0.31
CCR8 P51685 1/20 0.31
NOS3 P29474 1/20 0.31
NOS1 P29475 1/20 0.31
NOS2 P35228 1/20 0.31
SMN1; SMN2 Q16637 3/20 0.31
PDE2A O00408 1/20 0.31
P2RX3 P56373 1/20 0.31
P2RX2 Q9UBL9 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31350683 1.00 OPRK1 (0.36) OPRK1CYP11B1CYP11B2GLAKDM4E
SCHEMBL31350832 0.78 CHEK1 (0.37) CYP11B1CYP11B2GLAKDM4EMEN1
SCHEMBL7215518 0.74 CHRNB2 (0.42) OPRK1CYP11B1CYP11B2KDM4ENPSR1
SCHEMBL31350552 0.74 SMN1; SMN2 (0.40) CYP11B1CYP11B2KDM4EGAAMEN1
SCHEMBL11617655 0.74 GPR35 (0.41) GLAKDM4EGAASMN1; SMN2ALDH1A1
SCHEMBL11782988 0.73 CNR1 (0.44) GLAKDM4EGAASMN1; SMN2ALDH1A1
SCHEMBL21928132 0.72 CYP11B1 (0.38) OPRK1CYP11B1CYP11B2KDM4ENPSR1
SCHEMBL12772274 0.72 CDK1 (0.36) OPRK1CYP11B1CYP11B2KDM4ENPSR1
SCHEMBL625135 0.71 NOS3 (0.54) CYP11B1CYP11B2KDM4ENPSR1RXFP1
SCHEMBL3651726 0.71 NOS3 (0.39) OPRK1CYP11B1CYP11B2KDM4ENPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4743462-A1 COMPOUNDS COMPRISING A NAPHTHYRIDINE OR PYRIDOPYRIMIDINE CORE AS PTC READ-THROUGH AGENTS Tay Therapeutics Limited (GB) 2026-05-20 EP disclosed
WO-2025012643-A1 COMPOUNDS COMPRISING A NAPHTHYRIDINE OR PYRIDOPYRIMIDINE CORE AS PTC READ-THROUGH AGENTS Tay Therapeutics Limited (GB) 2025-01-16 WO disclosed